Skip to main content

Table 2 General patient characteristics and main PET parameters recorded or computed in the different groups imaged in clinical routine with the Vereos (digital-PET) or Ingenuity (analog-PET) camera and after the injection of 3 MBq.kg-1 of current 18F-labeled tracers, with an additional patient imaged after the injection of 7 MBq.kg-1 of 82Rb on the Vereos camera. Continuous variables are presented with median values [minimum – maximum values after exclusion of outliers]

From: Fully digital PET is unaffected by any deterioration in TOF resolution and TOF image quality in the wide range of routine PET count rates

 

Ingenuity TF

Vereos

Tracer type

18F-FDG

18F-Choline

18F-DOPA

18F-FDG

18F-Choline

18F-DOPA

82Rb

Number of patients

10

10

1

10

10

1

1

Gender

Female

Male

Female

Female

Male

Female

Male

Age (years)

76

[67-82]

70

[67-75]

72

71

[71-77]

72

[70-76]

65

55

Body weight (kg)

68

[65-69]

78

[74-84]

84

63

[59-69]

80

[77-81]

90

159

Injection-to-recording delay-time (min)

69

[65-72]

14

[12-17]

0

67

[65-74]

24

[17-25]

0

0

Recorded area

Whole body

Whole

body

Pelvis

Whole body

Whole

body

Pelvis

Thorax

Number of list-mode samples

18534

20757

2382

24814

21210

2401

961

Single count rate

(Mcps)

8.1

[5.8-10]

14.2

[7.4-21.7]

19.2

[17.7-20.1]

4.6

[2.3-6.0]

7.6

[3.7-12.6]

10.5

[7.9-13.3]

4.6

[0.5 29.5]

Corresponding activity concentration on NEMA phantom (kBq.mL-1)

2.9

[1.7-3.9]

6.2

[2.5-10.4]

9.0

[8.1-9.5]

2.9

[1.3-3.9]

5.1

[2.3-8.7]

7.2

[5.3-9.2]

3.0

[0.3-20.8]

Corresponding TOF resolution (ps)

631

[621-643]

677

[628-732]

713

[702-719]

328

[325-332]

Corresponding energy resolution (%)

11.36

[11.28-11.43]

11.6

[11.34-11.82]

11.7

[11.68-11.77]

11.01

[10.98-11.05]